Circulating matrix metalloproteinases and their endogenous inhibitors in patients with erectile dysfunction (2012)
- Autores:
- Autores USP: SANTOS, JOSE EDUARDO TANUS DOS - FMRP ; MARTINS, ANTONIO CARLOS PEREIRA - FMRP ; TUCCI JUNIOR, SILVIO - FMRP ; LACCHINI, RICCARDO - FMRP
- Unidade: FMRP
- DOI: 10.1038/ijir.2011.44
- Assuntos: DISFUNÇÃO ERÉTIL; METALOPROTEINASES; INIBIDORES DE ENZIMAS
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: International Journal of Impotence Research
- ISSN: 0955-9930
- Volume/Número/Paginação/Ano: v. 24, n. 1, p. 38-43, 2012
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
MUNIZ, J. J. et al. Circulating matrix metalloproteinases and their endogenous inhibitors in patients with erectile dysfunction. International Journal of Impotence Research, v. 24, n. 1, p. 38-43, 2012Tradução . . Disponível em: https://doi.org/10.1038/ijir.2011.44. Acesso em: 25 set. 2024. -
APA
Muniz, J. J., Lacchini, R., Belo, V. A., Nobre, Y. T. D. A., Tucci Júnior, S., Martins, A. C. P., & Tanus-Santos, J. E. (2012). Circulating matrix metalloproteinases and their endogenous inhibitors in patients with erectile dysfunction. International Journal of Impotence Research, 24( 1), 38-43. doi:10.1038/ijir.2011.44 -
NLM
Muniz JJ, Lacchini R, Belo VA, Nobre YTDA, Tucci Júnior S, Martins ACP, Tanus-Santos JE. Circulating matrix metalloproteinases and their endogenous inhibitors in patients with erectile dysfunction [Internet]. International Journal of Impotence Research. 2012 ; 24( 1): 38-43.[citado 2024 set. 25 ] Available from: https://doi.org/10.1038/ijir.2011.44 -
Vancouver
Muniz JJ, Lacchini R, Belo VA, Nobre YTDA, Tucci Júnior S, Martins ACP, Tanus-Santos JE. Circulating matrix metalloproteinases and their endogenous inhibitors in patients with erectile dysfunction [Internet]. International Journal of Impotence Research. 2012 ; 24( 1): 38-43.[citado 2024 set. 25 ] Available from: https://doi.org/10.1038/ijir.2011.44 - Comparative assessment of circulating matrix metalloproteinases and their endogenous inhibitors in erectile dysfunction
- Low nitric oxide bioavailability is associated with better responses to sildenafil in patients with erectile dysfunction
- Influence of arginase polymorphisms and arginase levels/activity on the response to erectile dysfunction therapy with sildenafil
- Relationship between asymmetric dimethylarginine, nitrite and genetic polymorphisms: impact on erectile dysfunction therapy
- VEGF genetic polymorphisms affect the responsiveness to sildenafil in clinical and postoperative erectile dysfunction
- Interethnic differences in the distribution of matrix metalloproteinases genetic polymorphisms are consistent with interethnic differences in disease prevalence
- Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases
- Increased activity of MMP-2 in hypertensive obese children is associated with hypoadiponectinemia
- Relationship between Arginase 1 and Arginase 2 levels and genetic polymorphisms with erectile dysfunction
- The effects of NAMPT haplotypes and metabolic risk factors on circulating visfatin/NAMPT levels in childhood obesity
Informações sobre o DOI: 10.1038/ijir.2011.44 (Fonte: oaDOI API)
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas